Findings

What do systematic reviews say?

3,234 questions · 3,357 findings · 396 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 803 · 23.9%GRADE not reported 270 · 8%Very low 757 · 22.5%Low 859 · 25.6%Moderate 486 · 14.5%High 182 · 5.4%

Intervention not reported

Stroke · Treating patients with traumatic brain injury

The intervention showed no clear difference in stroke (low certainty).

1 finding from 1 review

Antifibrinolytic drugs for acute traumatic injury 2015 · Cochrane Headline outcomes only
RR 0.34 [0.01, 8.35]
2 studies · 510 participants
Low

Intervention not reported

Deep vein thrombosis · Treating patients with traumatic brain injury

The intervention showed no clear difference in deep vein thrombosis (low certainty).

1 finding from 1 review

Antifibrinolytic drugs for acute traumatic injury 2015 · Cochrane Headline outcomes only
RR 0.25 [0.03, 2.26]
2 studies · 510 participants
Low

Intervention not reported

Surgical intervention · Treating bleeding trauma patients

The intervention showed no clear difference in surgical intervention (high certainty).

1 finding from 1 review

Antifibrinolytic drugs for acute traumatic injury 2015 · Cochrane Headline outcomes only
RR 1 [0.97, 1.03]
3 studies · 20437 participants
High

Intervention not reported

Blood transfusion · Treating bleeding trauma patients

The intervention showed no clear difference in blood transfusion (high certainty).

1 finding from 1 review

Antifibrinolytic drugs for acute traumatic injury 2015 · Cochrane Headline outcomes only
RR 0.98 [0.96, 1.01]
2 studies · 20367 participants
High

Intervention not reported

Myocardial infarction · Treating bleeding trauma patients

The intervention probably leads to lower myocardial infarction (moderate certainty).

1 finding from 1 review

Antifibrinolytic drugs for acute traumatic injury 2015 · Cochrane Headline outcomes only
RR 0.61 [0.4, 0.92]
2 studies · 20367 participants
Moderate

Intervention not reported

Deep vein thrombosis · Treating bleeding trauma patients

The intervention showed no clear difference in deep vein thrombosis (moderate certainty).

1 finding from 1 review

Antifibrinolytic drugs for acute traumatic injury 2015 · Cochrane Headline outcomes only
RR 0.95 [0.62, 1.47]
2 studies · 20367 participants
Moderate

Intervention not reported

Stroke · Treating bleeding trauma patients

The intervention showed no clear difference in stroke (moderate certainty).

1 finding from 1 review

Antifibrinolytic drugs for acute traumatic injury 2015 · Cochrane Headline outcomes only
RR 0.86 [0.61, 1.23]
2 studies · 20367 participants
Moderate

Intervention not reported

Pulmonary embolism · Treating bleeding trauma patients

The intervention showed no clear difference in pulmonary embolism (moderate certainty).

1 finding from 1 review

Antifibrinolytic drugs for acute traumatic injury 2015 · Cochrane Headline outcomes only
RR 1.01 [0.73, 1.41]
2 studies · 20367 participants
Moderate

Intervention not reported

Mortality · Treating patients with traumatic brain injury

The intervention may leads to lower mortality (low certainty).

1 finding from 1 review

Antifibrinolytic drugs for acute traumatic injury 2015 · Cochrane Headline outcomes only
RR 0.63 [0.4, 0.99]
2 studies · 510 participants
Low

Intervention not reported

Surgical intervention · Treating patients with traumatic brain injury

The intervention showed no clear difference in surgical intervention (low certainty).

1 finding from 1 review

Antifibrinolytic drugs for acute traumatic injury 2015 · Cochrane Headline outcomes only
RR 1.12 [0.65, 1.93]
2 studies · 510 participants
Low

Intervention not reported

PEI versus PAI · hospitalised people with early HCC treated with PEI, PAI, or surgery.

The review found no eligible studies for this question.

1 finding from 1 review

Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Overall survival · hospitalised people with early HCC treated with PEI, PAI, or surgery.

1 finding from 1 review

Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma 2015 · Cochrane Headline outcomes only
no estimate extracted
185 participants
Low

Intervention not reported

Recurrence‐free survival · hospitalised people with early HCC treated with PEI, PAI, or surgery.

1 finding from 1 review

Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma 2015 · Cochrane Headline outcomes only
no estimate extracted
185 participants
Low

Intervention not reported

Number and type of adverse events · hospitalised people with early HCC treated with PEI, PAI, or surgery.

The review found no eligible studies for this question.

1 finding from 1 review

Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Duration of hospital stay · hospitalised people with early HCC treated with PEI, PAI, or surgery.

1 finding from 1 review

Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma 2015 · Cochrane Headline outcomes only
no estimate extracted
125 participants
Very low

Intervention not reported

Quality of life · hospitalised people with early HCC treated with PEI, PAI, or surgery.

The review found no eligible studies for this question.

1 finding from 1 review

Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

PEI versus surgery · hospitalised people with early HCC treated with PEI, PAI, or surgery.

The review found no eligible studies for this question.

1 finding from 1 review

Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Improvement in measures of health behavior at 24 to 48 months of · s

1 finding from 1 review

Community coalition‐driven interventions to reduce health disparities among racial and ethnic minority populations 2015 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 29474 participants
Very low

Intervention not reported

Improvement in measures of health status at 24 to 60 months of · s

1 finding from 1 review

Community coalition‐driven interventions to reduce health disparities among racial and ethnic minority populations 2015 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 14431 participants
Very low

Intervention not reported

Improvement in measures of health status at 6 to 36 months of · s

1 finding from 1 review

Community coalition‐driven interventions to reduce health disparities among racial and ethnic minority populations 2015 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 21607 participants
Low